vs
Amplitude, Inc.（AMPL）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Amplitude, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$91.4M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -19.3%，领先403.3%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 17.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 12.2%）
Amplitude是一家美国企业，专注于研发数字分析软件，能够帮助企业梳理用户行为数据、优化产品决策与数字化运营体验。该公司于2021年9月28日在纳斯达克交易所挂牌上市，股票代码为AMPL。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AMPL vs RIGL — 直观对比
营收规模更大
AMPL
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出4.2%
17.0%
净利率更高
RIGL
高出403.3%
-19.3%
两年增速更快
RIGL
近两年复合增速
12.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $91.4M | $69.8M |
| 净利润 | $-17.7M | $268.1M |
| 毛利率 | 74.6% | 91.5% |
| 营业利润率 | -18.3% | 33.2% |
| 净利率 | -19.3% | 384.0% |
| 营收同比 | 17.0% | 21.2% |
| 净利润同比 | 45.8% | 1769.2% |
| 每股收益（稀释后） | $-0.13 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPLRIGL
| Q4 25 | $91.4M | $69.8M | ||
| Q3 25 | $88.6M | $69.5M | ||
| Q2 25 | $83.3M | $101.7M | ||
| Q1 25 | $80.0M | $53.3M | ||
| Q4 24 | $78.1M | $57.6M | ||
| Q3 24 | $75.2M | $55.3M | ||
| Q2 24 | $73.3M | $36.8M | ||
| Q1 24 | $72.6M | $29.5M |
净利润AMPLRIGL
| Q4 25 | $-17.7M | $268.1M | ||
| Q3 25 | $-24.0M | $27.9M | ||
| Q2 25 | $-24.7M | $59.6M | ||
| Q1 25 | $-22.2M | $11.4M | ||
| Q4 24 | $-32.6M | $14.3M | ||
| Q3 24 | $-16.9M | $12.4M | ||
| Q2 24 | $-23.4M | $-1.0M | ||
| Q1 24 | $-21.5M | $-8.2M |
毛利率AMPLRIGL
| Q4 25 | 74.6% | 91.5% | ||
| Q3 25 | 73.9% | 93.2% | ||
| Q2 25 | 72.6% | 95.6% | ||
| Q1 25 | 74.7% | 91.7% | ||
| Q4 24 | 74.7% | 89.9% | ||
| Q3 24 | 75.1% | 85.5% | ||
| Q2 24 | 73.4% | 92.4% | ||
| Q1 24 | 74.0% | 93.1% |
营业利润率AMPLRIGL
| Q4 25 | -18.3% | 33.2% | ||
| Q3 25 | -26.0% | 40.9% | ||
| Q2 25 | -29.0% | 60.1% | ||
| Q1 25 | -26.8% | 23.9% | ||
| Q4 24 | -41.2% | 28.9% | ||
| Q3 24 | -21.4% | 25.4% | ||
| Q2 24 | -31.7% | 1.2% | ||
| Q1 24 | -29.0% | -23.6% |
净利率AMPLRIGL
| Q4 25 | -19.3% | 384.0% | ||
| Q3 25 | -27.1% | 40.2% | ||
| Q2 25 | -29.6% | 58.6% | ||
| Q1 25 | -27.8% | 21.5% | ||
| Q4 24 | -41.7% | 24.9% | ||
| Q3 24 | -22.4% | 22.5% | ||
| Q2 24 | -31.9% | -2.8% | ||
| Q1 24 | -29.5% | -27.9% |
每股收益（稀释后）AMPLRIGL
| Q4 25 | $-0.13 | $14.11 | ||
| Q3 25 | $-0.18 | $1.46 | ||
| Q2 25 | $-0.19 | $3.28 | ||
| Q1 25 | $-0.17 | $0.63 | ||
| Q4 24 | $-0.25 | $0.82 | ||
| Q3 24 | $-0.14 | $0.70 | ||
| Q2 24 | $-0.19 | $-0.06 | ||
| Q1 24 | $-0.18 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $192.0M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $245.3M | $391.5M |
| 总资产 | $420.7M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AMPLRIGL
| Q4 25 | $192.0M | $155.0M | ||
| Q3 25 | $189.2M | $137.1M | ||
| Q2 25 | $208.1M | $108.4M | ||
| Q1 25 | $209.0M | $77.1M | ||
| Q4 24 | $241.1M | $77.3M | ||
| Q3 24 | $319.9M | $61.1M | ||
| Q2 24 | $318.3M | $49.1M | ||
| Q1 24 | $316.1M | $49.5M |
总债务AMPLRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益AMPLRIGL
| Q4 25 | $245.3M | $391.5M | ||
| Q3 25 | $262.2M | $117.6M | ||
| Q2 25 | $279.5M | $81.9M | ||
| Q1 25 | $289.5M | $18.6M | ||
| Q4 24 | $296.6M | $3.3M | ||
| Q3 24 | $290.0M | $-14.6M | ||
| Q2 24 | $287.3M | $-29.9M | ||
| Q1 24 | $289.2M | $-31.7M |
总资产AMPLRIGL
| Q4 25 | $420.7M | $513.6M | ||
| Q3 25 | $438.1M | $242.5M | ||
| Q2 25 | $456.6M | $206.7M | ||
| Q1 25 | $445.8M | $176.0M | ||
| Q4 24 | $445.9M | $164.0M | ||
| Q3 24 | $445.6M | $139.4M | ||
| Q2 24 | $445.4M | $128.4M | ||
| Q1 24 | $437.9M | $126.5M |
负债/权益比AMPLRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $12.7M | — |
| 自由现金流率自由现金流/营收 | 13.8% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $28.2M | — |
8季度趋势，按日历期对齐
经营现金流AMPLRIGL
| Q4 25 | $12.8M | $22.0M | ||
| Q3 25 | $5.0M | $24.0M | ||
| Q2 25 | $20.1M | $30.5M | ||
| Q1 25 | $-8.0M | $-893.0K | ||
| Q4 24 | $3.2M | $14.5M | ||
| Q3 24 | $6.2M | $21.7M | ||
| Q2 24 | $9.2M | $302.0K | ||
| Q1 24 | $-48.0K | $-5.0M |
自由现金流AMPLRIGL
| Q4 25 | $12.7M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $19.5M | — | ||
| Q1 25 | $-8.5M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $8.6M | — | ||
| Q1 24 | $-405.0K | — |
自由现金流率AMPLRIGL
| Q4 25 | 13.8% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 23.4% | — | ||
| Q1 25 | -10.6% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 8.2% | — | ||
| Q2 24 | 11.8% | — | ||
| Q1 24 | -0.6% | — |
资本支出强度AMPLRIGL
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.5% | — |
现金转化率AMPLRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPL
| US | $55.8M | 61% |
| International | $35.7M | 39% |
RIGL
暂无分部数据
